173 related articles for article (PubMed ID: 8097039)
21. Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.
Öngören Ş; Eşkazan AE; Berk S; Elverdi T; Salihoğlu A; Ar MC; Başlar Z; Aydın Y; Tüzüner N; Soysal T
Turk J Haematol; 2017 Dec; 34(4):291-299. PubMed ID: 29199176
[TBL] [Abstract][Full Text] [Related]
22. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
23. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
24. The disease with hope: hairy cell leukemia.
Becker SE
Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
[TBL] [Abstract][Full Text] [Related]
25. Hairy cell leukaemia.
Platanias LC; Golomb HM
Baillieres Clin Haematol; 1993 Dec; 6(4):887-98. PubMed ID: 7913637
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hairy cell leukaemia.
Lancet; 1990 Jul; 336(8708):149-50. PubMed ID: 1973476
[No Abstract] [Full Text] [Related]
28. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.
Rai KR
Leuk Lymphoma; 1994; 14 Suppl 1():107-8. PubMed ID: 7820040
[TBL] [Abstract][Full Text] [Related]
30. Advances in the treatment of hairy-cell leukaemia.
Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
[TBL] [Abstract][Full Text] [Related]
31. Hairy cell leukaemia: review of treatment.
Kurzrock R; Talpaz M; Gutterman JU
Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
[TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukaemia: the role of alpha interferon.
Platanias LC; Ratain MJ
Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hairy cell leukemia with alpha-interferon and splenectomy.
Tominaga S; Watanabe A; Higashi T; Hato S; Itoshima T; Hyodo I; Okushin H; Kita K; Nagashima H
J Med; 1987; 18(5-6):375-83. PubMed ID: 3505260
[TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: new understanding of biology and treatment.
Saven A; Piro LD; Carrera CJ; Carson DA; Beutler E
Cancer Treat Res; 1993; 64():15-34. PubMed ID: 7680875
[No Abstract] [Full Text] [Related]
35. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE
Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734
[TBL] [Abstract][Full Text] [Related]
36. Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
Zinzani PL; Stefoni V; Broccoli A; Pellegrini C; Gandolfi L; Casadei B; Maglie R; Pileri S; Argnani L
Ann Hematol; 2014 Sep; 93(9):1565-9. PubMed ID: 24752417
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia. Current management.
Doane LL; Ratain MJ; Golomb HM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
40. How I manage patients with hairy cell leukaemia.
Thompson PA; Ravandi F
Br J Haematol; 2017 May; 177(4):543-556. PubMed ID: 28146266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
